Barcelona, Spain

Miguel P Armengol

This inventor holds 2 USPTO granted patents. Top assignee: Ferrer Internacional, S.a.. Active years: 2005-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miguel P Armengol. Retrieved from https://idiyas.com/inventor/miguel-p-armengol

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2005-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Miguel P Armengol: Innovator in Pharmaceutical Processes

Introduction

Miguel P Armengol is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for synthesizing complex chemical compounds. With a total of 2 patents to his name, Armengol's work is recognized for its innovative approaches and practical applications.

Latest Patents

Armengol's latest patents include a process for preparing 3-(2-(4-(6-fluorobenzo(d)isoxazol-3-yl)-piperidin-1-yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)pyrimidin-4-one. This process involves condensing (2-methyl-6,7,8,9-tetrahydro-4 H-pyrido-[1,2-a]pyrimidin-3-yl)-acetaldehyde with 6-fluoro-3-piperidinyl)-1,2-benzisoxazole to yield an intermediate enamine. The second patent focuses on a process for preparing (±)trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine, which relates to the synthesis of compounds used in the production of Paroxetine and Omiloxetine.

Career Highlights

Armengol is currently associated with Ferrer Internacional, S.A., a company known for its commitment to innovation in the pharmaceutical sector. His work has contributed to advancements in drug development and has positioned him as a key figure in his field.

Collaborations

Throughout his career, Armengol has collaborated with notable colleagues such as Rafael Foguet and Jorge Ramentol. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Miguel P Armengol stands out as an influential inventor in the pharmaceutical industry. His innovative processes and collaborations have significantly impacted drug development, showcasing his dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…